Dimiracetam in Painful Neuropathies Affecting AIDS Patients

Summary

The purpose of this study is to assess the efficacy and tolerability of orally administered dimiracetam for 10 weeks to AIDS patients under treatment with antiretroviral agents presenting a disease and /or treatment related neuropathic pain.

Timeline

Start

2012-01

Primary completion

2013-01

Completion

2013-01

Drugs

Indications